Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates. (Q54130015)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

1 reference

Europe PubMed Central

Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates. (English)

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

author name string

M Dowzicky

1

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

H L Nadler

2

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

C Feger

3

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

G Talbot

4

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

F Bompart

5

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

M Pease

6

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

American Journal of Medicine

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

104

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

5A

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

34S-42S

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Antibiotic resistance and serotypes of Streptococcus pneumoniae at Birmingham Public Health Laboratory, 1989-94.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

RP 59500: a proposed mechanism for its bactericidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

The in-vitro activity of a new semi-synthetic streptogramin compound, RP 59500, against staphylococci and respiratory pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900153-3

7 January 2021

Identifiers

10.1016/S0002-9343(98)00153-3

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9684656

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54130015&oldid=1975632855"